683 Capital Management, LLC - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 119 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.

Quarter-by-quarter ownership
683 Capital Management, LLC ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$188,670
-8.2%
19,000
-35.6%
0.01%
-17.6%
Q4 2022$205,452
-94.5%
29,519
-95.8%
0.02%
-94.1%
Q3 2022$3,738,000
-6.3%
700,000
-30.0%
0.29%
+2.5%
Q2 2022$3,990,000
+79.5%
1,000,000
+100.0%
0.28%
+137.0%
Q1 2022$2,223,000
+49.5%
500,000
+130.6%
0.12%
+70.0%
Q4 2020$1,487,000
+21.6%
216,818
+31.4%
0.07%
-22.2%
Q3 2020$1,223,000
+77.8%
165,0000.0%0.09%
+63.6%
Q2 2020$688,000
-84.9%
165,000
-91.1%
0.06%
-79.6%
Q1 2020$4,568,000
-54.5%
1,850,000
+7.1%
0.27%
-76.6%
Q4 2019$10,038,000
-18.9%
1,727,700
-26.5%
1.15%
-16.6%
Q3 2019$12,384,000
-2.9%
2,350,000
+10.5%
1.38%
+18.7%
Q2 2019$12,755,000
-21.5%
2,125,781
+18.1%
1.16%
-21.3%
Q1 2019$16,254,000
+40.5%
1,800,000
+29.2%
1.47%
+110.3%
Q4 2018$11,568,000
-37.9%
1,393,700
+3.2%
0.70%
-42.0%
Q3 2018$18,630,000
+134.3%
1,350,000
+35.0%
1.21%
+125.1%
Q2 2018$7,950,000
+6.0%
1,000,0000.0%0.54%
-19.0%
Q1 2018$7,500,000
+20.5%
1,000,000
+9.3%
0.66%
+26.3%
Q4 2017$6,222,000
+3.4%
915,000
+9.5%
0.52%
-16.9%
Q3 2017$6,016,000
+146.4%
835,514
+59.1%
0.63%
+75.6%
Q2 2017$2,442,000525,0930.36%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 1,009,131$7,568,0001.15%
Knoll Capital Management, LLC 124,096$931,0000.96%
683 Capital Management, LLC 1,000,000$7,500,0000.66%
Perceptive Advisors 3,085,458$23,141,0000.65%
MANGROVE PARTNERS IM, LLC 324,019$2,430,0000.16%
Stanley-Laman Group, Ltd. 64,029$480,0000.11%
WOODSTOCK CORP 67,759$508,0000.10%
Hikari Power Ltd 107,858$809,0000.10%
ARDSLEY ADVISORY PARTNERS LP 45,000$336,0000.05%
ADAGE CAPITAL PARTNERS GP, L.L.C. 750,000$5,625,0000.01%
View complete list of ALDEYRA THERAPEUTICS INC shareholders